Concord Medical Services Holdings Ltd (CCM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Concord Medical Services Holdings Ltd (CCM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8060
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Concord Medical Services Holdings Ltd (CMS) is a diagnostic imaging center that offers clinical support services and laboratory services. The center offers radiotherapy and diagnostic imaging equipment services such as head gamma knife systems, body gamma knife systems and linear accelerators. It also provides positron emission tomography-computed tomography scanners and magnetic resonance imaging scanners. CMS offers clinical support services to doctors working in medical and clinical centers. The center offers radiotherapy and diagnostic equipment leasing and management services to hospitals and consulting services. It operates through a network of centers and hospitals across China. CMS is headquartered in Beijing, China.

Concord Medical Services Holdings Ltd (CCM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Concord Medical Services Completes Acquisition Of 19.98% Stake In MD Anderson Cancer Center Proton Therapy Center From PTC-Houston Management 10
Partnerships 12
Concord Medical Enters into Co-Development Agreement with MD Anderson 12
Chang’An Hospital Enters Into Agreement With Fox Chase Cancer Center 13
Acquisition 14
Concord Medical Services Acquires Additional Stake in MD Anderson Proton Therapy Center from PTC-Houston Management 14
Concord Medical to Acquire Fortis Surgical for USD40 Million 15
Concord Medical Services to Divest 52% Stake in Chang’An Hospital for USD65 Million 16
Concord Medical Completes Acquisition Of 52% Stake In Chang’An Hospital For US$37 Million 17
Concord Medical Services Holdings Ltd – Key Competitors 18
Concord Medical Services Holdings Ltd – Key Employees 19
Concord Medical Services Holdings Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Affiliate 20
Joint Venture 20
Recent Developments 22
Strategy And Business Planning 22
Sep 21, 2017: Concord Medical Announces Construction of Shanghai Concord Cancer Hospital 22
Financial Announcements 23
Aug 29, 2018: Concord Medical Services Holdings announces financial results for the first half of 2018 23
Aug 25, 2017: Concord Medical Reports Financial Results for the First Half of 2017 26
Corporate Communications 28
Sep 18, 2017: Concord Medical Announces Changes to the Board 28
Jul 24, 2017: Concord Medical Announces Changes to the Board 29
Other Significant Developments 30
Jun 29, 2017: Concord Medical Announces Construction of Proton Treatment Building of Beijing Proton Medical Center 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concord Medical Services Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Concord Medical Services Completes Acquisition Of 19.98% Stake In MD Anderson Cancer Center Proton Therapy Center From PTC-Houston Management 10
Concord Medical Enters into Co-Development Agreement with MD Anderson 12
Chang'An Hospital Enters Into Agreement With Fox Chase Cancer Center 13
Concord Medical Services Acquires Additional Stake in MD Anderson Proton Therapy Center from PTC-Houston Management 14
Concord Medical to Acquire Fortis Surgical for USD40 Million 15
Concord Medical Services to Divest 52% Stake in Chang'An Hospital for USD65 Million 16
Concord Medical Completes Acquisition Of 52% Stake In Chang'An Hospital For US$37 Million 17
Concord Medical Services Holdings Ltd, Key Competitors 18
Concord Medical Services Holdings Ltd, Key Employees 19
Concord Medical Services Holdings Ltd, Subsidiaries 20
Concord Medical Services Holdings Ltd, Affiliate 20
Concord Medical Services Holdings Ltd, Joint Venture 20

List of Figures
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concord Medical Services Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Concord Medical Services Holdings Ltd (CCM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hangzhou Tigermed Consulting Co Ltd (300347):企業の財務・戦略的SWOT分析
    Summary Hangzhou Tigermed Consulting Co Ltd (Tigermed) is a contract research organization (CRO) that provides clinical trial services. It offers regulatory submission and approval, medical translation and GMP (Good Manufacturing Practice) consulting, medical monitoring, project management, medical …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Karur Vysya Bank Ltd:企業の戦略・SWOT・財務情報
    Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Delphi Energy Corp (DEE):企業の財務・戦略的SWOT分析
    Delphi Energy Corp (DEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Melinta Therapeutics Inc (MLNT):企業の財務・戦略的SWOT分析
    Melinta Therapeutics Inc (MLNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Mitsubishi Corporation:戦略・SWOT・企業財務分析
    Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ergon, Inc.:石油・ガス:M&Aディール及び事業提携情報
    Summary Ergon Inc (Ergon) is an integrated energy company that carries out the exploration and production of crude oil and natural gas, processing, transportation and terminaling of crude oil, storage, marketing and distribution of specialty petroleum products. The company also manufactures and mark …
  • AAR Corp:戦略・SWOT・企業財務分析
    AAR Corp - Strategy, SWOT and Corporate Finance Report Summary AAR Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Arvind Ltd:企業の戦略・SWOT・財務情報
    Arvind Ltd - Strategy, SWOT and Corporate Finance Report Summary Arvind Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • KfW Group:企業の戦略・SWOT・財務分析
    KfW Group - Strategy, SWOT and Corporate Finance Report Summary KfW Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Verde Science Inc (VRCI):企業の財務・戦略的SWOT分析
    Summary Verde Science Inc (Verde Science), formerly Rango Energy Inc is a pharmaceutical research and development company that explores phytochemicals and drugs to create novel formulations. The company offers research and development services in bioprocess technology, molecular virology and immunol …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides r …
  • All in West! Capital Corp:企業の戦略・SWOT・財務分析
    All in West! Capital Corp - Strategy, SWOT and Corporate Finance Report Summary All in West! Capital Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • A. Menarini Diagnostics Srl:医療機器:M&Aディール及び事業提携情報
    Summary A. Menarini Diagnostics Srl (Menarini Diagnostics), a subsidiary of A Menarini Industrie Farmaceutiche Riunite Srl is a medical device company that offers in-vitro diagnostic products. The company provides pharmaceutical testing products including home glucose testing products, oral anticoag …
  • Jaiprakash Power Ventures Ltd (JPPOWER):電力:M&Aディール及び事業提携情報
    Summary Jaiprakash Power Ventures Ltd (Jaiprakash Power) is a power utility. It plans, develops, implements, and operates electric projects. The company produces electricity using hydro and coal sources. Jaiprakash Power also has development interests in the Hirong hydroelectric project and the Lowe …
  • Connecticut Children’s Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Connecticut Children's Medical Center (CCMC) is a children’s hospital that offers primary care and residency and fellowship programs in pediatrics. The hospital offers services such as allergy and immunology, anesthesiology, asthma center, audiology, ccmc school, cancer and blood disorders, …
  • Tiziana Life Sciences Plc (TILS):企業の財務・戦略的SWOT分析
    Tiziana Life Sciences Plc (TILS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SciClone Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SciClone Pharmaceuticals Inc (SciClone), a subsidiary of Silver Biotech Investment Ltd, develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin) is an immunostimulatory agent indicate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆